Glimepiride Strongly Enhances the Glucose-Lowering Effect in Triple Oral Antidiabetes Therapy with Sitagliptin and Metformin for Japanese Patients with Type 2 Diabetes Mellitus
Diabetes Technology & Therapeutics Apr 2013, Vol. 15, No. 4: 335-341.
Source: Diabetes Technology - Category: Endocrinology Tags: article Source Type: research
More News: Diabetes | Diabetes Mellitus | Diabetes Type 2 | Endocrinology | Fortamet | Glimepiride | Janumet | Januvia | Metformin